A ground-breaking prostate cancer treatment that aims to target tumours without as many side effects has showed promising ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at EPFL, and Eneda Toska at Johns Hopkins University have identified the enzyme ...

North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for ...

Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

ETHealthworld.com brings latest cancer research news, views and updates from all top sources for the Indian Health industry.

PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...

Prostate Cancer UK said a 42 per cent rise in diagnoses in the past decade is thanks to increased awareness of the disease by ...